Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8625
Corporate User License Price USD 375
Corporate User License Price INR 25875
Site License Price USD 250
Site License Price INR 17250
Request a Quote

Report Title

Ipsen SA (IPN)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Ipsen SA (IPN)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Ipsen SA (IPN)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Ipsen SA (IPN)-Financial and Strategic SWOT Analysis Review



Executive Summary

Ipsen SA (IPN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ipsen SA (Ipsen) is a global specialty biotechnology company that manufactures and distributes drugs for the treatment of cancer and endocrine and neurological diseases. The company's portfolio of therapies focus at treating neuroendocrine tumors, prostate, bladder and kidney cancer, pituitary diseases, growth disorders precocious puberty, spasticity, cervical dystonia, hemifacial spasm, blepharospasm, gastrointestinal disorders, neurodegenerative pathologies, gout and other diseases. It has research and development facilities in Les Ulis, France; Oxford, the UK; and Cambridge, the US. The company provides products in Europe, North America, Asia and rest of the world. Ipsen is headquartered in Paris, France. Ipsen is headquartered in Paris, France.

Ipsen SA Key Recent Developments

Jul 27,2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017

Jun 01,2017: Ipsen To Present New Data of Investigational Compound Ga-OPS201 at ASCO in Line with its Continued Commitment to Oncology Research

Apr 27,2017: Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1

Apr 14,2017: Ipsen appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer

Mar 02,2017: Ipsen appoints Benoit Hennion as Executive Vice President and President, Primary Care

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Ipsen SA-Key Facts 6

Ipsen SA-Key Employees 7

Ipsen SA-Key Employee Biographies 9

Ipsen SA-Major Products and Services 10

Ipsen SA-History 12

Ipsen SA-Company Statement 13

Ipsen SA-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Affiliate 16

Joint Venture 16

Section 2-Company Analysis 17

Ipsen SA-Business Description 17

Ipsen SA-Corporate Strategy 18

Ipsen SA-SWOT Analysis 19

SWOT Analysis-Overview 19

Ipsen SA-Strengths 19

Ipsen SA-Weaknesses 20

Ipsen SA-Opportunities 21

Ipsen SA-Threats 23

Ipsen SA-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32

Ipsen SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33

Ipsen SA, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Jul 27, 2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017 35

Jun 01, 2017: Ipsen To Present New Data of Investigational Compound Ga-OPS201 at ASCO in Line with its Continued Commitment to Oncology Research 43

Apr 27, 2017: Ipsen Reports Strong First Quarter 2017 Sales Growth of 19,1%1 44

Apr 14, 2017: Ipsen appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer 47

Mar 02, 2017: Ipsen appoints Benoit Hennion as Executive Vice President and President, Primary Care 48

Feb 23, 2017: Ipsen delivers strong 2016 results and expects further sales growth and margin enhancement for 2017 49

Feb 06, 2017: Ipsen announces appointment of Dr. Sotirios G. Stergiopoulos as Head of Global Medical Affairs 57

Jan 20, 2017: Ipsen appoints Harout Semerjian as President, Head of Specialty Care International Region & Global Franchises 58

Dec 12, 2016: Ipsen announces departure of EVP of R&D and chief scientific officer 59

Dec 12, 2016: Claude Bertrand to step down as Executive Vice President, R&D, Chief Scientific Officer of Ipsen 60

Section 6-Appendix 61

Methodology 61

Ratio Definitions 61

About GlobalData 65

Contact Us 65

Disclaimer 65

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Ipsen SA, Performance Chart (2012-2016) 29

Ipsen SA, Ratio Charts 31

Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32

Ipsen SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 33

List of Tables

Ipsen SA, Key Facts 6

Ipsen SA, Key Employees 7

Ipsen SA, Key Employee Biographies 9

Ipsen SA, Major Products and Services 10

Ipsen SA, History 12

Ipsen SA, Subsidiaries 14

Ipsen SA, Affiliate 16

Ipsen SA, Joint Venture 16

Ipsen SA, Key Competitors 24

Ipsen SA, Ratios based on current share price 25

Ipsen SA, Annual Ratios 26

Ipsen SA, Annual Ratios (Cont...1) 27

Ipsen SA, Annual Ratios (Cont...2) 28

Ipsen SA, Interim Ratios 30

Ipsen SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32

Ipsen SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33

Ipsen SA, Recent Deals Summary 34

Currency Codes 61

Capital Market Ratios 61

Equity Ratios 62

Profitability Ratios 62

Cost Ratios 63

Liquidity Ratios 63

Leverage Ratios 64

Efficiency Ratios 64

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Ipsen SA, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person